| Name | Title | Contact Details |
|---|
"Eleven uses its proprietary technology platform to create first-of-a-kind protein therapeutics to address unmet needs for ophthalmic diseases. Proteins are able to modulate inflammatory cytokines, key targets in ocular disease that have been difficult to access with conventional therapeutic approaches. A significant untapped opportunity exists for protein therapeutics to address ophthalmic diseases, and Eleven is applying its advanced protein technology and expertise to develop innovative medicines for patients suffering from ocular diseases. Eleven`s team of industry veterans has deep experience in understanding protein science and biologic drug development, designing and conducting clinical trials and, most importantly, applying specific expertise in ophthalmic disease to create novel ocular therapeutics to treat unmet medical needs. Eleven has developed a proprietary pipeline of ophthalmic drug candidates derived from the company`s innovative AMP-Rx protein engineering technology. The company`s initial product candidates are focused on targeting inflammatory cytokines and key targets of ocular disease by blocking the cytokines and modulating the biological processes that drive ocular disease. Current pipeline opportunities include ocular surface diseases such as dry eye disease (DED) and allergic conjunctivitis (AC), and back of the eye diseases such as diabetic macular edema (DME) and uveitis. In addition, Eleven’s proprietary technology has been utilized to prolong the intravitreal half-life of our pipeline products. Beyond its internal drug development programs, Eleven works with collaborators, such as ThromboGenics, to apply its innovative protein therapeutic design capabilities to engineer and develop biotherapeutic products for additional therapeutic targets. EBI-005, Eleven`s lead product candidate, is a novel interleukin-1 (IL-1) receptor antagonist in Phase 3 clinical development as one of the first topically administered proteins for the treatment of DED and AC, two inflammatory diseases at the surface of the eye."
Health Quality Council of Alberta is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Community Health & Wellness Center of Greater Torrington is a healthcare provider committed to providing quality, compassionate, and professional health care that is affordable, easily accessible and without discrimination to all residents of the n...
Headquartered in NYC, Hometeam empowers caregivers to deliver high-quality home care for older adults, a population in the US that`s growing at a rapid pace. Our custom technology enhances our delivery of care, but it`s our employees who make a tangible impact on people`s lives everyday. Whether you`re a Caregiver in the field or a Software Engineer in our corporate office, Hometeam provides employees the opportunity to elevate the standards of home care in America.
Nautilus Healthcare Management Group is a Newport Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.